Arrhythmias & electrophysiology
Cardiac implantable electronic device patient follow-up: Assessment of U.S. practice
Authors' conclusion
Although most Medicare beneficiaries were seen in-office in the year following a new implant, the percentage of beneficiaries with an in-office visit declined in subsequent years. Fewer than 5% of beneficiaries had remote monitoring at the frequency recommended by the expert consensus statement. Patient demographics, including older age, nonwhite race, and lower income were associated with a lower likelihood of receiving care concordant with consensus statement recommendations.
Study context
- Population
- Medicare beneficiaries with implantation of a new cardiac implantable electronic device, October 2015–December 2020
- Participants
- 211,346 beneficiaries
- Outcome
- Rate of follow-up office visits and remote monitoring (care concordant with consensus statement recommendations)
Main finding
As reported in the abstract
- Seen in-office for postoperative evaluation within 16 weeks of implantation
- 77.8%
- Seen in office in first 12 months
- 85.9%
- Seen in office every 2 years postimplantation
- 64.2%
- Remote monitoring in first 91 days
- 14.7%
- Remote monitoring every 91 days within first year
- 4.4%
Observational data: associations, not effects.
Further findings
Office visits by patient characteristics
- Patients ≥85 years old, nonwhite, or of lower income less likely to receive office visits postimplantation
Original publication
Cardiac implantable electronic device patient follow-up: Assessment of U.S. practice. Heart Rhythm. Published 11 October 2024. doi:10. 1016/ j. hrthm. 2024. 10. 014
Composed by AI from the published abstract and checked against it. How Briefs are made →